| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.03. | OSE Immunotherapeutics - KOL event highlights lusvertikimab's potential | 267 | Edison Investment Research | OSE Immunotherapeutics and Edison held a key opinion leader (KOL) event on 5 March 2025, providing up-to-date insights into OSE's lead immuno-inflammation candidate, lusvertikimab, following the European... ► Artikel lesen | |
| 07.03. | Severfield - Full year trading update disappoints | 264 | Edison Investment Research | Trading conditions have not improved as hoped for in the second half of the current financial year, which has resulted in a reduction in Severfield's expected outcome for FY25. This weakness is reflected... ► Artikel lesen | |
| 07.03. | Patria Private Equity Trust - An attractive route to the PE mid-market | 269 | Edison Investment Research | Patria Private Equity Trust (formerly known as abrdn Private Equity Opportunities Trust) allows investors to gain exposure to a gradually rebounding private equity (PE) market via a trust active in... ► Artikel lesen | |
| 07.03. | Informa - FY25-28 plan for leveraging B2B platform | 283 | Edison Investment Research | Informa used its FY24 results presentation to highlight its strategy for the next three years. This is centred on leveraging the One Informa platform, focused on B2B, through its market-leading brands... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 2.947 |
| TESLA | 2.156 |
| STEYR MOTORS | 2.121 |
| DEUTZ | 1.988 |
| RENK GROUP | 1.892 |
| TUI | 1.786 |
| THYSSENKRUPP | 1.563 |
| RHEINMETALL | 1.561 |
| NEL | 1.442 |
| BYD | 1.418 |
| BAYER | 1.121 |
| EVOTEC | 994 |
| NOVO NORDISK | 973 |
| DEUTSCHE BANK | 887 |
| XIAOMI | 841 |
| COMMERZBANK | 794 |
| BASF | 789 |
| VOLKSWAGEN | 776 |
| MERCEDES-BENZ | 720 |
| AIXTRON SE | 687 |
| PUMA | 671 |
| PORSCHE AG | 669 |
| HENSOLDT | 647 |
| BARRICK GOLD | 633 |
| MUTARES | 627 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
